Research output per year
Research output per year
Fingerprint
Dive into the research topics where Philippe Parola is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Relevant Research
- 40 Article
-
Asymptomatic hypoxia in COVID-19 is associated with poor outcome
Brouqui, P., Amrane, S., Million, M., Cortaredona, S., Parola, P., Lagier, J. C. & Raoult, D., 1 Jan 2021, In: International Journal of Infectious Diseases. 102Research output: Contribution to journal › Article › peer-review
Open Access -
Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19 (Insights into Imaging, (2020), 11, 1, (117), 10.1186/s13244-020-00939-7)
Castelli, M., Maurin, A., Bartoli, A., Dassa, M., Marchi, B., Finance, J., Lagier, J. C., Million, M., Parola, P., Brouqui, P., Raoult, D., Cortaredona, S., Jacquier, A., Gaubert, J. Y. & Habert, P., 1 Dec 2021, In: Insights into Imaging. 12, 1Research output: Contribution to journal › Article › peer-review
Open Access -
COVID-19 re-infection
Brouqui, P., Colson, P., Melenotte, C., Houhamdi, L., Bedotto, M., Devaux, C., Gautret, P., Million, M., Parola, P., Stoupan, D., La Scola, B., Lagier, J. C. & Raoult, D., 1 Jan 2021, In: European Journal of Clinical Investigation.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France
Edouard, S., Colson, P., Melenotte, C., Di Pinto, F., Thomas, L., La Scola, B., Million, M., Tissot-Dupont, H., Gautret, P., Stein, A., Brouqui, P., Parola, P., Lagier, J. C., Raoult, D. & Drancourt, M., 1 Feb 2021, In: European Journal of Clinical Microbiology and Infectious Diseases. 40, 2Research output: Contribution to journal › Article › peer-review
Open Access -
Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
Million, M., Giraud-Gatineau, A., Lagier, J. C., Parola, P., Gautret, P. & Raoult, D., 1 Jan 2021, In: Travel Medicine and Infectious Disease. 39Research output: Contribution to journal › Article › peer-review
Press / Media
-
The true face of Covid-19: Fear and "shock therapy" to impose a totalitarian society
5/08/20
1 item of Media coverage
Press/Media
-
The True Face of Covid-19: Fear and “Shock Therapy” to Impose a Totalitarian Society?
29/07/20
1 item of Media coverage
Press/Media
-
Treatment of COVID-19 patients with hydroxychloroquine showed no benefit: research
23/06/20
1 item of Media coverage
Press/Media
-
Politicized medicine against covid-19 manages to sow discord
Didier Raoult, Philippe Parola & Neil W. Schluger
5/06/20
1 item of Media coverage
Press/Media
-
Miracle or mirage, one politicized COVID-19 medicine sows discord
Didier Raoult, Philippe Parola & N. W. Schluger
4/06/20 → 5/06/20
14 items of Media coverage
Press/Media